クリティカルケア診断の世界市場：2025年から2030年までの予測

クリティカルケア診断市場は、2025年の16億6,503万5,000米ドルから2030年には22億4,448万4,000米ドルに成長し、CAGRは6.15%と予測されます。

クリティカルケア診断市場は、生命を脅かす重篤な患者や末期患者に対する迅速かつ正確な診断ソリューションに対するニーズの高まりにより、2025～2030年にかけて力強い成長が見込まれています。がんバイオマーカースクリーニング、心臓マーカー診断、薬剤乱用検査、病原体スクリーニング、コレステロール検査などの検査を含むこれらの診断は、医師が迅速に病気を診断し、タイムリーな治療を開始することを可能にします。この市場は、慢性疾患の有病率の上昇と先進的診断技術の採用拡大によって推進されているが、設備コストの高騰や熟練した専門家の不足といった課題が市場の進展を阻害している可能性があります。

市場促進要因

クリティカルケア診断市場は、慢性疾患、特に心疾患やがんの罹患率の上昇に牽引されています。これらの疾患の世界の重荷により、迅速かつ正確な結果を提供し、医師が遅滞なく十分な情報に基づいた治療決定を下せるような検査に対する需要が高まっています。さらに、ヘルスケア専門家によるクリティカルケア診断の採用が拡大していることも、大きな成長要因となっています。侵襲的・非侵襲的モニタリング装置によってサポートされるこれらの診断は、正確さとスピードが最重要視される集中治療環境にますます不可欠になっています。診断プラットフォームの技術的進歩は、信頼性とアクセシビリティをさらに高め、市場拡大を後押ししています。

市場抑制要因

成長の可能性はあるも、クリティカルケア診断市場は注目すべき課題に直面しています。分子検査プラットフォームや画像診断システムなどの先進的診断機器のコストが高いため、特に資源に制約のあるヘルスケア環境では導入が制限される可能性があります。さらに、複雑な診断システムの操作や結果の解釈に習熟した専門家の不足は、特に開発途上地域において大きな障壁となっています。これらの制約は、費用対効果の高い技術革新やトレーニングプログラムの強化を通じて対処しない限り、市場の成長を妨げる可能性があります。

目次

第1章 エグゼクティブサマリー

第2章 市場スナップショット

• 市場概要
• 市場の定義
• 調査範囲
• 市場セグメンテーション

第3章 ビジネス情勢

• 市場促進要因
• 市場抑制要因
• 市場機会
• ポーターのファイブフォース分析
• 産業バリューチェーン分析
• 施策と規制
• 戦略的提言

第4章 技術展望

第5章 クリティカルケア診断の世界市場：タイプ別

• イントロダクション
• 血液学
• 心臓と脂質検査
• 凝固検査
• 微生物と感染症検査
• その他

第6章 クリティカルケア診断の世界市場：エンドユーザー別

• イントロダクション
• 病院
• 診断センター
• 在宅ケア
• その他

第7章 クリティカルケア診断の世界市場：地域別

• イントロダクション
• 北米
  • タイプ別
  • 用途別
  • 国別
    • 米国
    • カナダ
    • メキシコ
• 南米
  • タイプ別
  • 用途別
  • 国別
    • ブラジル
    • アルゼンチン
    • その他
• 欧州
  • タイプ別
  • 用途別
  • 国別
    • ドイツ
    • フランス
    • 英国
    • スペイン
    • その他
• 中東・アフリカ
  • タイプ別
  • 用途別
  • 国別
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • その他
• アジア太平洋
  • タイプ別
  • 用途別
  • 国別
    • 中国
    • インド
    • 日本
    • 韓国
    • インドネシア
    • タイ
    • その他

第8章 競合環境と分析

• 主要企業と戦略分析
• 市場シェア分析
• 合併、買収、合意とコラボレーション
• 競合ダッシュボード

第9章 企業プロファイル

• Abbott Laboratories
• bioMerieux SA
• Danaher Corporation
• Radiometer Medical ApS
• Trivitron Healthcare
• Siemens Healthcare GmbH
• Becton Dickinson Company
• Bayer AG
• Roche Diagnostics
• Bio-Rad Laboratories, Inc.

第10章 付録

• 通貨
• 前提条件
• 基準年と予測年のタイムライン
• 利害関係者にとっての主要メリット
• 調査手法
• 略語

The global critical care diagnostics market is expected to grow from USD1,665.035 million in 2025 to USD2,244.484 million in 2030, at a CAGR of 6.15%.

The critical care diagnostics market is poised for robust growth from 2025 to 2030, driven by the increasing need for rapid and accurate diagnostic solutions for critically ill or terminally ill patients with life-threatening conditions. These diagnostics, encompassing tests such as cancer biomarker screening, cardiac marker diagnostics, drug abuse testing, pathogen screening, and cholesterol testing, enable physicians to diagnose diseases swiftly and initiate timely treatment. The market is propelled by the rising prevalence of chronic diseases and the growing adoption of advanced diagnostic technologies, though challenges like high equipment costs and a shortage of skilled professionals may impede progress.

Market Drivers

The critical care diagnostics market is primarily driven by the rising incidence of chronic diseases, notably cardiac conditions and cancer, which require sophisticated diagnostic tools for effective management. The global burden of these diseases has increased demand for tests that provide rapid and precise results, enabling physicians to make informed treatment decisions without delay. Additionally, the growing adoption of critical care diagnostics by healthcare professionals is a significant growth factor. These diagnostics, supported by invasive and non-invasive monitoring devices, are increasingly integral to intensive care settings, where accuracy and speed are paramount. Technological advancements in diagnostic platforms further enhance their reliability and accessibility, boosting market expansion.

Market Restraints

Despite its growth potential, the critical care diagnostics market faces notable challenges. The high cost of advanced diagnostic equipment, such as molecular testing platforms and imaging systems, can limit adoption, particularly in resource-constrained healthcare settings. Additionally, a shortage of skilled professionals trained to operate complex diagnostic systems and interpret results poses a significant barrier, especially in developing regions. These constraints may hinder market growth unless addressed through cost-effective innovations and enhanced training programs.

Market Segmentation

By Application

The critical care diagnostics market is segmented into hematology, cardiac and lipid testing, coagulation testing, microbial and infectious disease testing, and others. Cardiac and lipid testing holds a significant share due to the high prevalence of cardiovascular diseases, necessitating rapid biomarker diagnostics. Microbial and infectious disease testing is also growing, driven by the need for early detection of pathogens in critical care settings. Hematology and coagulation testing remain vital for managing blood-related disorders, while other applications, such as cancer biomarker testing, are gaining traction due to rising cancer rates.

By End Users

The market is segmented into diagnostic centers, research laboratories, home care settings, and others. Diagnostic centers dominate due to their advanced infrastructure and capacity to handle high-throughput testing for critically ill patients. Research laboratories contribute to market growth through the development of novel diagnostic technologies. Home care settings are emerging as a growing segment, driven by the increasing availability of portable diagnostic devices, which enable monitoring and testing outside traditional healthcare facilities.

By Geography

The global critical care diagnostics market is segmented into North America, South America, Europe, the Middle East and Africa (MEA), and Asia-Pacific. North America leads due to its advanced healthcare infrastructure, high adoption of cutting-edge diagnostics, and significant prevalence of chronic diseases. Europe follows closely, supported by robust research and development activities. The Asia-Pacific region is expected to witness rapid growth, driven by increasing healthcare investments and rising disease burdens in countries like China and India. South America and MEA are also projected to grow, supported by improving healthcare access and awareness.

Key Industry Players

Major players in the critical care diagnostics market include companies focused on developing innovative diagnostic solutions. These players are investing in research, strategic partnerships, and product launches to strengthen their market positions. The report highlights their competitive strategies, financial performance, and recent developments, emphasizing their role in advancing diagnostic technologies.

The critical care diagnostics market is set for significant growth from 2025 to 2030, driven by the rising prevalence of chronic diseases and the adoption of advanced diagnostic tools. While high costs and a shortage of skilled professionals present challenges, the market's outlook remains positive, particularly in North America, Europe, and Asia-Pacific. Industry players must focus on affordability, training, and technological innovation to capitalize on the growing demand for rapid and accurate diagnostics in critical care settings.

Key Benefits of this Report:

• Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
• Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
• Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
• Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
• Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

• Historical data from 2020 to 2024 & forecast data from 2025 to 2030
• Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
• Competitive Positioning, Strategies, and Market Share Analysis
• Revenue Growth and Forecast Assessment of segments and regions including countries
• Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Global Critical Care Diagnostics Market Segmentation

By Type

• Haematology
• Cardiac and Lipid Testing
• Coagulation Testing
• Microbial and Infectious Disease Testing
• Others

By End-User

• Hospitals
• Diagnostics Centers
• Home Care Setting
• Others

By Geography

• North America
• USA
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Others
• Europe
• Germany
• France
• United Kingdom
• Spain
• Others
• Middle East and Africa
• Saudi Arabia
• UAE
• Israel
• Others
• Asia Pacific
• China
• India
• Japan
• South Korea
• Indonesia
• Thailand
• Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

• 2.1. Market Overview
• 2.2. Market Definition
• 2.3. Scope of the Study
• 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Porter's Five Forces Analysis
• 3.5. Industry Value Chain Analysis
• 3.6. Policies and Regulations
• 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET BY TYPE

• 5.1. Introduction
• 5.2. Haematology
• 5.3. Cardiac and lipid Testing
• 5.4. Coagulation Testing
• 5.5. Microbial and Infectious Disease Testing
• 5.6. Others

6. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET BY END-USER

• 6.1. Introduction
• 6.2. Hospitals
• 6.3. Diagnostics Centers
• 6.4. Home Care Settings
• 6.5. Others

7. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET BY GEOGRAPHY

• 7.1. Introduction
• 7.2. North America
  • 7.2.1. ByType
  • 7.2.2. By Application
  • 7.2.3. By Country
    • 7.2.3.1. USA
    • 7.2.3.2. Canada
    • 7.2.3.3. Mexico
• 7.3. South America
  • 7.3.1. By Type
  • 7.3.2. By Application
  • 7.3.3. By Country
    • 7.3.3.1. Brazil
    • 7.3.3.2. Argentina
    • 7.3.3.3. Others
• 7.4. Europe
  • 7.4.1. By Type
  • 7.4.2. By Application
  • 7.4.3. By Country
    • 7.4.3.1. Germany
    • 7.4.3.2. France
    • 7.4.3.3. United Kingdom
    • 7.4.3.4. Spain
    • 7.4.3.5. Others
• 7.5. Middle East and Africa
  • 7.5.1. By Type
  • 7.5.2. By Application
  • 7.5.3. By Country
    • 7.5.3.1. Saudi Arabia
    • 7.5.3.2. UAE
    • 7.5.3.3. Israel
    • 7.5.3.4. Others
• 7.6. Asia Pacific
  • 7.6.1. By Type
  • 7.6.2. By Application
  • 7.6.3. By Country
    • 7.6.3.1. China
    • 7.6.3.2. India
    • 7.6.3.3. Japan
    • 7.6.3.4. South Korea
    • 7.6.3.5. Indonesia
    • 7.6.3.6. Thailand
    • 7.6.3.7. Others

8. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 8.1. Major Players and Strategy Analysis
• 8.2. Market Share Analysis
• 8.3. Mergers, Acquisitions, Agreements, and Collaborations
• 8.4. Competitive Dashboard

9. COMPANY PROFILES

• 9.1. Abbott Laboratories
• 9.2. bioMerieux SA
• 9.3. Danaher Corporation
• 9.4. Radiometer Medical ApS
• 9.5. Trivitron Healthcare
• 9.6. Siemens Healthcare GmbH
• 9.7. Becton Dickinson Company
• 9.8. Bayer AG
• 9.9. Roche Diagnostics
• 9.10. Bio-Rad Laboratories, Inc.

10. APPENDIX

• 10.1. Currency
• 10.2. Assumptions
• 10.3. Base and Forecast Years Timeline
• 10.4. Key Benefits for the Stakeholders
• 10.5. Research Methodology
• 10.6. Abbreviations